Damian Garde

@statnews reporter / [email protected] / Signal: damiangarde.67

[Lizzy Lawrence @LizzyLaw_]

NEW: Many of the new members of an FDA committee who will be advising the agency on peptides are involved with businesses that promote and prescribe peptides. More w/ @SarahLizChar here:

https://t.co/h9Y62e97tR

[Jason Mast @Jasonmmast]

Moderna co-founder Kenneth Chien on the future of mRNA — and Moderna  https://t.co/snNX2vqpgG

[Allison DeAngelis @ADeAngelis_bio]

One of the firms behind Metsera has tapped an AI scientist co. to create new biotechs 🤖

[Damian Garde @damiangarde]

“If the patient is dead, you wouldn’t hear about it.” The ERs that can turn patients away — and are reaping millions. https://t.co/Z6G5IhJpj0

[Lizzy Lawrence @LizzyLaw_]

Very interesting explainer from @cooney_liz on pulmonary hypertension, and why the new class of obesity drugs might help: https://t.co/wT7H3156ad

[Damian Garde @damiangarde]

Biosecure didn’t stop China’s rise in biotech. Some lawmakers want to do more https://t.co/HWz2oz3M0S

[Damian Garde @damiangarde]

U.S. health spending rose sharply in 2025, thanks to GLP-1 use and more care https://t.co/7ok6v8DvVR

[Jason Mast @Jasonmmast]

RIP Sangamo

[Mario Aguilar @mariojoze]

FDA drops enforcement against Whoop after it tweaks blood pressure feature https://t.co/PUlX2EjDIJ via @statnews

[Jason Mast @Jasonmmast]

RA Capital, RTW others put $230 million behind a new Chinese-founded competitor to $Beam Therapeutics

https://t.co/FlTGdEdRMO

[Lizzy Lawrence @LizzyLaw_]

EXCLUSIVE: Eli Lilly gave compassionate use access to retatrutide, their unapproved powerful obesity drug, to a 79-year-old man in April. The application was arranged by a top doctor at NIH, and cleared by the FDA.
https://t.co/bakw09t4D3

[Damian Garde @damiangarde]

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? https://t.co/N9bhK4TlrS

[Adam Feuerstein ✡️ @adamfeuerstein]

Closely watched Pfizer lung cancer drug falls short in clinical trial https://t.co/YVTtQtba1G via @matthewherper $PFE

[Damian Garde @damiangarde]

FDA to launch pilot program to speed up early-stage clinical trials https://t.co/e8lNUOGtK7

[Jason Mast @Jasonmmast]

Pharma goes on a spending spree, snapping up biotechs in a hurry

Via @ADeAngelis_bio

https://t.co/0rXE40mHCr

[Jason Mast @Jasonmmast]

Never a dull day in biotech land

Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval https://t.co/gJ3Qu4eOvp

[Josh Hart @joshhart]

FROM NOW ON ADDRESS ME AS CHAMP! 🧡💙

[Damian Garde @damiangarde]

Is death optional? Inside the big business of the longevity movement https://t.co/4Mj2QvVK26

[Lizzy Lawrence @LizzyLaw_]

HIRING ALERT: STAT is looking for a reporter to cover declining trust in science. This reporter will examine the forces eroding the authority of scientific institutions and mainstream medicine. Apply here:
https://t.co/NJ8bhGrfiP

[Adam Feuerstein ✡️ @adamfeuerstein]

STAT housekeeping note: We'll be on the ground in Chicago next week for #ASCO26.

The STAT@ASCO live event is Fri. May 29. I will be chatting on stage w/ $RVMD CEO Mark Goldsmith. I wonder what we'll talk about?

We also have Rick Pazdur on stage, always entertaining, especially these days...

Register here: https://t.co/93f5sqBpDq